Showing results (201-210 of 276) with videos related to
Sort By:
Pageof 28
Annals of the Rheumatic Diseases|November 29, 2007
Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patientsT C van der Pouw Kraan, C A Wijbrandts, L G van Baarsen, et al.Annals of the Rheumatic Diseases|October 16, 2004
Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritisG J Wolbink, A E Voskuyl, W F Lems, et al.Arthritis and Rheumatism|January 1, 2008
Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose studyP P Tak, R M Thurlings, C Rossier, et al.Annals of the Rheumatic Diseases|August 30, 2008
Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritisC A Wijbrandts, S I van Leuven, H D Boom, et al.Arthritis and Rheumatism|July 1, 1996
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritisP P Tak, P C Taylor, F C Breedveld, et al.Annals of the Rheumatic Diseases|November 16, 2014
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritisD L Boyle, K Soma, J Hodge, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritisM M Maurice, A C Lankester, A C Bezemer, et al.Rheumatology (Oxford, England)|October 30, 2007
Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammationC E Vergunst, D M Gerlag, H Dinant, et al.Annals of the Rheumatic Diseases|July 15, 2009
Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritisR M Thurlings, O Teng, K Vos, et al.Oral Diseases|October 24, 2006
NOD mouse model for Sjögren's syndrome: lack of longitudinal stabilityB M Lodde, F Mineshiba, M R Kok, et al.Pageof 28